about
HPLC-UV analytical method for determination of pizotifen after in vitro transdermal diffusion studies.Progress in the development of early diagnosis and a drug with unique pharmacology to improve cancer therapyImpact of Undernutrition on the Pharmacokinetics and Pharmacodynamics of Anticancer Drugs: A Literature Review.A UHPLC-UV Method to Quantify Skin Deposition and Transdermal Permeation of Tizanidine HydrochlorideSynthesis of 3-azabicyclo[3.2.2]nonanes and their antiprotozoal activities.Influence of polyunsaturated fatty acids on Cortisol transport through MDCK and MDCK-MDR1 cells as blood-brain barrier in vitro model.Unique pharmacology of KAR-2, a potential anti-cancer agent: absorption modelling and selective mitotic spindle targeting.Bioactivity of Ceftazidime and Fluconazole Included in Polymethyl Methacrylate Bone Cement for Use in Arthroplasty.Development of antimigraine transdermal delivery systems of pizotifen malate.Improving oral bioavailability and pharmacokinetics of liposomal metformin by glycerolphosphate-chitosan microcomplexation.Using transdermal iontophoresis to increase granisetron delivery across skin in vitro and in vivo: effect of experimental conditions and a comparison with other enhancement strategies.Development and evaluation of occlusive systems employing polyvinyl alcohol for transdermal delivery of sumatriptan succinate.A dopamine transport inhibitor with markedly low abuse liability suppresses cocaine self-administration in the rat.PAMPA--a drug absorption in vitro model 7. Comparing rat in situ, Caco-2, and PAMPA permeability of fluoroquinolones.Effect of iontophoresis on in vitro transdermal absorption of almotriptan.Variability of permeability estimation from different protocols of subculture and transport experiments in cell monolayers.The dopamine uptake inhibitor 3 alpha-[bis(4'-fluorophenyl)metoxy]-tropane reduces cocaine-induced early-gene expression, locomotor activity, and conditioned reward.Effect of chemical enhancers on the in vitro percutaneous absorption of sumatriptan succinate.Enhancement of nortriptyline penetration through human epidermis: influence of chemical enhancers and iontophoresis.Mathematical modelling of in situ and in vitro efflux of ciprofloxacin and grepafloxacin.Antibiotic-loaded Bone Cement as Prophylaxis in Total Joint Replacement.Functional Magnetic Mesoporous Silica Microparticles Capped with an Azo-Derivative: A Promising Colon Drug Delivery Device.Levofloxacin effect on erlotinib absorption. Evaluation of the interaction in undernutrition situations through population pharmacokinetic analysis in rats.Hydroxypropylmethylcellulose films for the ophthalmic delivery of diclofenac sodium.Intrinsic absolute bioavailability prediction in rats based on in situ absorption rate constants and/or in vitro partition coefficients: 6-fluoroquinolones.Validation of a biophysical drug absorption model by the PATQSAR system.A preclinical study to model taurine pharmokinetics in the undernourished rat.Ionic Hydrogel Based on Chitosan Cross-Linked with 6-Phosphogluconic Trisodium Salt as a Drug Delivery System.Transdermal therapeutic systems for memantine delivery. Comparison of passive and iontophoretic transport.Controlled iontophoretic transport of huperzine A across skin in vitro and in vivo: effect of delivery conditions and comparison of pharmacokinetic models.Impact of nutritional status on the pharmacokinetics of erlotinib in rats.Transdermal nortriptyline hydrocloride patch formulated within a chitosan matrix intended to be used for smoking cessationSmart gated magnetic silica mesoporous particles for targeted colon drug delivery: New approaches for inflammatory bowel diseases treatmentMesoporous silica microparticles gated with a bulky azo derivative for the controlled release of dyes/drugs in colonDesign, characterization and in vitro evaluation of 5-aminosalicylic acid loaded N-succinyl-chitosan microparticles for colon specific deliveryIn Situ Study of the Effect of Naringin, Talinolol and Protein-Energy Undernutrition on Intestinal Absorption of Saquinavir in RatsN-Succinyl-chitosan systems for 5-aminosalicylic acid colon delivery: In vivo study with TNBS-induced colitis model in ratsPopulation modelling to describe pharmacokinetics of amiodarone in rats: Relevance of plasma protein and tissue depot bindingTherapeutic efficacy of quercetin enzyme-responsive nanovesicles for the treatment of experimental colitis in ratsBioadhesive monolayer film for the in vitro transdermal delivery of sumatriptan.
P50
Q34048822-9414E67F-6E45-48F0-A403-427A663A62EAQ37226769-0234C9C2-5BD6-44B2-BE7D-97502B2A81E2Q38869469-CA28312A-43B1-43D3-AA49-D634F07513AFQ39176454-8AD3497B-8D8F-4F5D-BC7B-94D9B0D6649AQ39443397-0E3A95DB-6146-4980-8954-5502A111C4DDQ39616390-220E07C7-E5A6-4EE4-9E0E-93D2274A8597Q39912968-F5E7D34F-1BC2-4067-9869-16616A6A6659Q40142625-F049C0D6-FCB0-45F5-9896-31A0CE0FD22CQ40713557-A72837D7-7200-41A0-BD84-2582A6029020Q41125054-C361D981-7CF7-4A19-9284-B067BF2EB892Q43185733-2E20F3F0-316E-49C7-9E40-26D416B3A62BQ43196458-0E4462DB-E518-408B-A15D-8382AC0A0A38Q43276178-380209DB-30EE-4B07-9F11-F05302541778Q44785032-CF305528-9B4C-4362-BA5E-6B2E4BC050B5Q44968143-F4E92027-42C2-4548-B134-393065C0E30AQ45893532-F6CE0B94-904E-4B0E-8909-DC0C9B4BA421Q45928219-F8CB66DD-7A30-4FF6-8C20-154E1BC34F95Q46518682-5E7680B5-0307-4BDB-BB23-090191576106Q46670581-D70520EE-7A10-4202-8A5B-9336919282B4Q46780589-BDD5F8CC-72DD-41BF-A6A3-8BF494B51FEDQ47816072-80E29C92-59A8-4E4B-A2B6-5A8793E5BA89Q50034266-F330791C-0940-4069-8C01-1AEA0B1A7386Q50947265-65F5F8FA-8848-4B0D-8770-65EC58AB3B65Q51282117-C418598D-7D39-4368-9A1F-54A16FFF329BQ52073169-B24C2A7F-B6FA-41D1-8D65-39E06329AC7EQ52219483-8A5A15BE-8D5B-44D3-9A44-C79F62C170BBQ52640971-2F568559-3852-4CC8-99F1-CB3633F58753Q52656241-FB30B724-6FAC-4669-AE29-AF1336839A42Q53760806-3242166B-C193-463F-B038-F4AD23CF7FE9Q54231745-59B3946A-E1CC-44D0-B9D0-5A2297ECBA21Q54284937-707D0BAA-844A-4E0F-9079-29464C7EA766Q57382831-2F7D695B-8F13-46D9-90BD-BA7B57C8FC8AQ57401015-315B7664-3427-4B6D-9742-53DB1A2675B4Q58776288-9CA9FD64-42D1-474C-9A73-3881B5C12E87Q60929302-2059C45C-FFF7-45ED-BC99-45FDBE81A1C6Q60929357-CCCD0EFF-1E19-41B9-BCFF-543202A4D5D6Q60929370-D9CA6814-A992-4039-B5CB-480CC994CBB3Q60929428-19770199-698F-419F-93C8-4828CF271691Q61160065-98A1934B-05CB-4D1B-9D29-45EF71DFD1CEQ61763031-061668C7-1BAC-43CB-9A0C-DCDEA007F826
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Virginia Merino
@ast
Virginia Merino
@en
Virginia Merino
@es
Virginia Merino
@nl
type
label
Virginia Merino
@ast
Virginia Merino
@en
Virginia Merino
@es
Virginia Merino
@nl
prefLabel
Virginia Merino
@ast
Virginia Merino
@en
Virginia Merino
@es
Virginia Merino
@nl
P106
P1153
7003800026
P21
P31
P496
0000-0003-2220-4664